CX3CL1 and COVID-19: This proposed mechanism, supported by prior literature, suggests that CX3CL1-mediated immune cell recruitment may amplify pulmonary damage through excessive inflammation, while elevated D-dimer reflects COVID-19-associated coagulopathy driving thrombosis.